Shawnna Fitzwater
Family · Henderson, NVNPI 1962715946
Payments from drug & device makers
Across 88 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$425
- Novo Nordisk$236
- Amgen$163
- AstraZeneca$163
- Lundbeck LLC$112
- Biohaven Pharmaceuticals, Inc.$96
- plus $575 from 15 others
What the payments were for
- Food & beverage$1,73898%
- Education$322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $425 |
| Novo Nordisk | 7 | $236 |
| Amgen | 9 | $163 |
| AstraZeneca(2 entities) | 9 | $163 |
| Lundbeck LLC | 4 | $112 |
| Biohaven Pharmaceuticals, Inc. | 6 | $96 |
| Tanabe Pharma America, Inc. | 4 | $83 |
| Argenx US, Inc. | 3 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $59 |
| Avanir Pharmaceuticals, Inc. | 3 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| SK Life Science, Inc. | 2 | $39 |
| CSL Behring | 2 | $38 |
| Lilly USA, LLC | 2 | $28 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Intra-sana Laboratories | 1 | $18 |
| Abbott | 1 | $17 |
| Acorda Therapeutics, Inc | 1 | $17 |
| Pfizer | 1 | $15 |
| Exact Sciences | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$107
How this compares
$1,770 in reported general payments places this provider in the 80th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $15,566 |
| Atorvastatin Calcium | 39 | $405 |
| Losartan Potassium | 17 | $239 |
| Amlodipine Besylate | 27 | $226 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 13 | $218 |
| Pantoprazole Sodium | 12 | $99 |
| Alprazolam | 15 | $59 |
| Levothyroxine Sodium | 15 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $15,56619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,501 family providers in Nevada.
Other family in Henderson
- Kristy SolisHenderson$23K
- Joseph LauHenderson$18K
- Judith YuHenderson$14K
- Daniel Sam AciertoHenderson$11K
- Reiko TapiaHenderson$10K
- Francis TorresHenderson$8K
- John PhoenixLas Vegas$281K
- Hollie TylerLas Vegas$118K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.